Zou, H., Guo, Y., Goetz, C. G., Mestre, T. A., Stebbins, G. T., Al-Hajraf, F., … Luo, S. (2024). Co-Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications. Mov Disord Clin Pract, 11(3), 312–314. https://doi.org/10.1002/mdc3.13890

Zou, Haotian, Yuanyuan Guo, Christopher G. Goetz, Tiago A. Mestre, Glenn T. Stebbins, Falah Al-Hajraf, Michael Lawton, Michele Hu, and Sheng Luo. “Co-Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications.” Mov Disord Clin Pract 11, no. 3 (March 2024): 312–14. https://doi.org/10.1002/mdc3.13890.

Zou H, Guo Y, Goetz CG, Mestre TA, Stebbins GT, Al-Hajraf F, et al. Co-Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications. Mov Disord Clin Pract. 2024 Mar;11(3):312–4.

Zou, Haotian, et al. “Co-Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications.” Mov Disord Clin Pract, vol. 11, no. 3, Mar. 2024, pp. 312–14. Pubmed, doi:10.1002/mdc3.13890.

Zou H, Guo Y, Goetz CG, Mestre TA, Stebbins GT, Al-Hajraf F, Lawton M, Hu M, Luo S. Co-Existent Probable RBD and PD: Disease Progression, Medication Response, and Clinical Trial Implications. Mov Disord Clin Pract. 2024 Mar;11(3):312–314.